Pharmacies: A Key Player in HIV Prevention Strategies

Researchers from the University of Bristol are sounding the alarm: if we want to meet the government’s ambitious goal of ending new HIV transmissions by 2030, community pharmacies must be fully integrated into national HIV prevention strategies.

Insights from Groundbreaking Research

These urgent recommendations stem from the innovative ‘Accessing PrEP through pharmacies to improve HIV prevention’ study, which marks England's first pilot scheme providing pre-exposure prophylaxis (PrEP) directly via community pharmacies.

Conducted between October 2024 and April 2025 in five pharmacies across Bristol, North Somerset, and South Gloucestershire, this pilot has revealed incredibly promising insights.

Breaking Down Barriers for Better Access

The researchers urge critical changes, including modifications to NHS policy to allow pharmacies to stock and dispense PrEP, a planned rollout for long-acting injectable PrEP in such locations, and a smoother reimbursement process to encourage pharmacies to participate.

Despite the pilot's conclusion, the findings are enlightening. Out of 55 consultations conducted, 28 patients showed interest in PrEP, yet only four were prescribed it—a clear indicator that greater awareness and accessibility is needed.

Pharmacies: Accessible, Trusted, and Less Stigmatizing

Participants noted that pharmacies are viewed as more approachable than sexual health clinics, thus offering a more welcoming environment for those seeking help. However, many pharmacists lacked confidence in discussing PrEP due to a general lack of awareness about it within both the community and pharmacy teams.

A Call for Comprehensive Training and Support

Co-lead researcher Jeremy Horwood emphasizes the necessity for extensive training for pharmacy staff, alongside directed campaigns to boost public awareness. The potential for pharmacies to enhance the reach of HIV prevention tools is immense, especially in underserved communities.

The Future of HIV Prevention in UK Pharmacies

Lead author China Harrison reinforces that while PrEP is a phenomenal weapon against HIV, current access methods aren’t effectively reaching all those who could benefit. With the right support, pharmacies could revolutionize access and help the government achieve the ambitious goal of eradicating new transmissions by 2030.

Voices from the Community: Expert Opinions

Commenting on the findings, Nathan Burley from NHS Greater Glasgow and Clyde noted the importance of determining which aspects of PrEP care can feasibly be delivered in pharmacies. He argued that the higher associated costs in primary care currently deter many from adopting such models.

Further support from prescribing community pharmacists is seen as essential in tackling the growing need for accessible sexual health services.

A Unified Call to Action

Tase Oputu from the Royal Pharmaceutical Society highlighted the crucial role pharmacies can play in reaching marginalized communities. He urged for appropriate training, clear care pathways, and sustainable funding to pave the way for expanded PrEP access.

As the government develops its ‘Neighbourhood Health Service,’ there’s a pressing need to act on recommendations to enhance PrEP availability through community pharmacies, ensuring the forthcoming HIV action plan is both practical and effective.